Related Experiment Videos
Hypercalcaemia and calcitonin inhibit prolactin secretion.
Experimental and Clinical Endocrinology
|December 1, 1984
Summary
Acute hypercalcaemia and calcitonin both inhibit prolactin (PRL) secretion. These findings suggest a potential link between calcium levels and PRL regulation, though the exact mechanism remains unclear.
Area of Science:
- Endocrinology
- Reproductive Biology
- Calcium Metabolism
Background:
- Prolactin (PRL) is a key hormone regulating numerous physiological processes.
- The lactotrophic cells in the pituitary gland are responsible for PRL secretion.
- Hormonal and metabolic factors can significantly influence PRL release.
Purpose of the Study:
- To investigate the impact of acute hypercalcaemia on prolactin secretion.
- To examine the effect of synthetic salmon calcitonin on prolactin secretion.
- To compare the prolactin-inhibiting effects of hypercalcaemia and calcitonin.
Main Methods:
- Acute hypercalcaemia was induced via intravenous calcium gluconate infusion.
- Lactotrophic secretory reserve was assessed using insulin hypoglycaemia tests.
- Synthetic salmon calcitonin was administered intravenously, and its effects were evaluated using TRH tests.
Main Results:
- Acute hypercalcaemia significantly inhibited both basal and insulin-stimulated prolactin levels (p < 0.01).
- Calcitonin administration reduced resting and TRH-stimulated prolactin levels (p < 0.05 and p < 0.01, respectively).
- Both hypercalcaemia and calcitonin significantly reduced the prolactin response to stimuli (delta PRL, p < 0.01).
Conclusions:
- Acute hypercalcaemia exerts an inhibitory effect on prolactin secretion.
- Synthetic salmon calcitonin also demonstrates a significant prolactin-inhibiting effect.
- The prolactin-inhibiting actions of calcitonin closely resemble those of hypercalcaemia, suggesting a potential shared regulatory pathway.